Experience

Da Vinci Labs

• France
• Research Services
• 1 - 100 Employee

• EU Project Coordinator

  • Sep 2022 - Present

  PAT4CGT ProjectAutomated online monitoring & control to improve processes and decision making in Cell and Gene Therapy manufacturing.Pat4CGT aims to enable in-line continuous monitoring of key cell culture parameters during therapy manufacturing. To do this, we will create a self-contained instrument that connects miniaturized biosensor technologies to a novel bioreactor to allow automation of the entire cell therapy manufacturing process in a closed system. Our platform will carry out continuous, automated, and closed monitoring of a set of well-defined CPPs, as indicators of the overall state of the cell culture. This will greatly lower costs and risks associated with manual sampling.



Kekkan Biologics

• France
• Biotechnology Research

• Director Of Operations

  • Feb 2022 - Present

  A platform company developing first-in-class biologics against severe neovascular and fibrotic disorders A platform company developing first-in-class biologics against severe neovascular and fibrotic disorders



Core Technologies for Life Sciences

• France
• Civic and Social Organizations
• 1 - 100 Employee

• Director

  • Apr 2019 - Jan 2022

  Core Technologies for Life Sciences (CTLS) is an international non-profit association that brings together scientists, technical and administrative staff working at or with shared resource laboratories, such as core facilities, scientific platforms and research infrastructures. CTLS is a platform to network, discuss emerging technologies, exchange information on benchmarks and best practices, and support the career development of its members. We promote and advocate the added value in using open shared resource laboratories as platforms for efficient and productive scientific research. http://www.ctls-org.eu/



eHealth Hub

• Italy
• Hospitals and Health Care

• Member of the Advisory Board

  • Apr 2017 - Dec 2021

  Multifaceted business support for eHealth startups:• Business Modelling• Access to Private Finance• Commercialisation • Legal and Regulatory Compliancehttp://www.ehealth-hub.eu/ Multifaceted business support for eHealth startups:• Business Modelling• Access to Private Finance• Commercialisation • Legal and Regulatory Compliancehttp://www.ehealth-hub.eu/



Ville de Nice

• France
• Government Administration
• 200 - 300 Employee

• Head of International Healthcare Projects and Partnerships

  • Jan 2016 - Jan 2018

  Providing the intellectual, conceptual, technical and managerial leadership for a comprehensive portfolio of projects focused on innovating the city’s healthcare and social support systemProjects include piloting and evaluation of new eHealth technologies, implementation of innovative investment mechanisms e.g. Social Impact Investment via Social Impact Bonds, multi-prong initiatives to support local start-ups focused on eHealthDetermining the strategic framework, structural relationships and geographical scope of new healthcare initiatives Developing the priorities and implementation plans for projects that have the potential to improve the social and economic outcomes for the community Building and maintaining relationships with key European and international partners including the public sector, investors and industryStrengthening interregional and international collaborations through facilitating effective representation of the city’s healthcare ecosystem Performing and supporting technology assessment and technology transfer activitiesJudging competitions for start-ups focused on healthcareServing as a member of the city’s Healthcare Innovation Committee (Comité Innovation Santé)



Living Labs Global

• Government Administration
• 1 - 100 Employee

• Director of Operations

  • Mar 2014 - Jun 2015

  Providing consulting services in the areas of innovative procurement and procurement of biomedical innovation. Clients included hospitals as well as med tech and e-health companies across the EU.Leading the following business functions at LLG: health economics research, business development, marketing, development of a proprietary IT platform in support of an innovative model of procurement. Specialties: health economics, pharmaceutical & med tech economics, healthcare policy research, value strategy creation, reimbursement strategy, health technology assessment (HTA and mini-HTA).Co-led the implementation of a European program focused on procurement of innovative healthcare technologies across several jurisdictions within the EUConsulted healthcare providers across the EU with respect to a wide range of challenges for efficient delivery of healthcare services;Developed "Calls for Solutions" to invite technology providers to compete for opportunities in improving healthcare delivery;Collaborated with major corporate, governmental and NGO stakeholders to build strategic partnerships around FI-STAR health initiative.



Whiteshield Partners

• United Kingdom
• Public Policy Offices
• 1 - 100 Employee

• Investment Associate, Biomedical Sector

  • Jul 2011 - Feb 2014

  Identified and evaluated potential investment opportunities among innovative biomedical companies focused on pharmaceuticals, medical devices (therapeutic and diagnostic), regenerative technologies and cell medicine.Analysed potential market impact, competitive advantages, IP, HR and technological strengths of candidate companies. Supported business development, negotiation of deals and contracts.Collaborated with management teams of start-up companies on budget and business plan development, creation of technical documents, investment memoranda and presentations to investorsManaged relationships with multiple stakeholders: innovators, entrepreneurs, academics, clinicians and co-investment partnersAlumni Profile: http://www.whiteshieldpartners.com/alumni.php?content=alumni



The London School of Economics and Political Science (LSE)

• United Kingdom
• Higher Education
• 700 & Above Employee

• MSc Biomedicine, Bioscience, Society

  • Aug 2009 - May 2011

  Program Description: social and economic evaluation of biomedical innovation Key Research Topics: pharmaceutical R&D, economics, and marketing; biobanking; stem cells; biological enhancement; synthetic biology; biocapital; bioethics; policy making and regulation of biolmedical innovationCourses: Health Economics; Key Issues in Bioscience, Biomedicine and Society; Key Methods for the Studies of Bioscience, Biomedicine and Society; Health Policy; Global Environmental Governance.Dissertation Title: "Social Implications of Personalized Medicine in the Context of Bioeconomy"



Biovail

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Clinical Research Coordinator

  • Jul 2008 - Aug 2009

  Coordinated and managed all aspects of complex clinical studies at the CRO Reviewed and developed critical study documentation (e.g. clinical protocols and ICFs) Supervised screening/recruitment of volunteers Monitored clinical operations and data collection Created and reviewed final ICH compliant study reports for FDA/TPD submissionsLed and supported up to twenty clinical staff members Co-led the implementation of company-wide strategic initiatives (e.g. electronic data collection)



Allied Research International

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Clinical Study Coordinator

  • Aug 2006 - Jun 2008



Mount Sinai Hospital (Toronto), Sinai Health

• Canada
• Hospitals and Health Care
• 700 & Above Employee

• Research Associate

  • Sep 2003 - Mar 2004

  Under supervision of Dr. Paul Walfish, worked on the development of methods for diagnosis of residual/recurrent papillary-follicular thyroid cancer. Under supervision of Dr. Paul Walfish, worked on the development of methods for diagnosis of residual/recurrent papillary-follicular thyroid cancer.